We are live on ! Find out more
VYGR icon

Voyager Therapeutics
VYGR

121 hedge funds and large institutions have $277M invested in Voyager Therapeutics in 2020 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 49 increasing their positions, 37 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,056% more call options, than puts

Call options by funds: $194K | Put options by funds: $9K

32% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 37

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

1.73% less ownership

Funds ownership: 83.23% → 81.5% (-1.7%)

12% less funds holding

Funds holding: 138 → 121 (-17)

36% less capital invested

Capital invested by funds: $430M → $277M (-$153M)

64% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 25

Holders
121
Holders Change
-17
Holders Change %
-12.32%
% of All Funds
2.67%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
9
Increased
49
Reduced
37
Closed
25
Calls
$194K
Puts
$9K
Net Calls
+$185K
Net Calls Change
-$632K

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$7.02M
2
Bank of New York Mellon
Bank of New York Mellon
New York
+$3.91M
3
BlackRock
BlackRock
New York
+$3.33M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$2.66M
5
ClearBridge Investments
ClearBridge Investments
New York
+$2.25M

Top Sellers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
-$6.29M
2
Citadel Advisors
Citadel Advisors
Florida
-$4.39M
3
FCMI
Foresite Capital Management IV
California
-$3.6M
4
UBS AM
UBS AM
Illinois
-$3.21M
5
Millennium Management
Millennium Management
New York
-$3.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
TGI
1
TRV GP III
Massachusetts
$58.5M – – –
BG
2
Bellevue Group
Switzerland
$24.9M +$227K +19,800 +0.7%
BlackRock
3
BlackRock
New York
$22M +$3.33M +290,158 +14%
Vanguard Group
4
Vanguard Group
Pennsylvania
$21.3M +$2.66M +231,887 +11%
AC
5
Armistice Capital
New York
$20.5M +$7.02M +612,000 +38%
State Street
6
State Street
Massachusetts
$12.5M +$505K +44,002 +3%
ClearBridge Investments
7
ClearBridge Investments
New York
$11.1M +$2.25M +196,342 +19%
CC
8
Casdin Capital
New York
$10M – – –
Renaissance Technologies
9
Renaissance Technologies
New York
$9.54M -$2.33M -202,700 -16%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$8.22M +$3.91M +340,650 +61%
FCMI
11
Foresite Capital Management IV
California
$4.73M -$3.6M -313,814 -38%
Federated Hermes
12
Federated Hermes
Pennsylvania
$4.37M -$6.29M -547,964 -53%
Wells Fargo
13
Wells Fargo
California
$4.19M +$796K +69,335 +18%
Wellington Management Group
14
Wellington Management Group
Massachusetts
$4.18M -$252K -21,973 -5%
Goldman Sachs
15
Goldman Sachs
New York
$3.84M +$21.1K +1,834 +0.4%
N
16
Nuveen
North Carolina
$3.79M -$2.57K -224 -0.1%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$3.63M +$145K +12,641 +3%
Northern Trust
18
Northern Trust
Illinois
$3.15M +$96.1K +8,373 +2%
EAM
19
Erste Asset Management
Austria
$3.03M +$149K +13,000 +4%
JP Morgan Chase
20
JP Morgan Chase
New York
$2.67M +$716K +62,349 +27%
Acadian Asset Management
21
Acadian Asset Management
Massachusetts
$2.11M +$481K +41,923 +22%
Fidelity Investments
22
Fidelity Investments
Massachusetts
$2.1M – – –
Millennium Management
23
Millennium Management
New York
$2.03M -$3.1M -270,365 -55%
Charles Schwab
24
Charles Schwab
California
$1.89M +$17.4K +1,515 +0.7%
RJFSA
25
Raymond James Financial Services Advisors
Florida
$1.78M +$438K +38,148 +24%
1
2 3 4 5

VYGR Hedge Fund Activity: Q1 2020 in Review

121 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Voyager Therapeutics (VYGR) for Q1 2020, worth a combined $277M — down 36% from $430M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of VYGR and 9 opened new positions — a net loss of 16 holders — while 37 trimmed existing stakes and 49 added.

The largest buyer was Armistice Capital, adding an estimated $7.02M. The largest seller was Federated Hermes, cutting an estimated $6.29M.

  • 121 institutional investors held Voyager Therapeutics (VYGR) as of Q1 2020, down from 138 in Q4 2019.
  • Funds reported $277M of Voyager Therapeutics stock for Q1 2020, down 36% quarter-over-quarter.
  • 9 funds opened new Voyager Therapeutics positions in Q1 2020 and 25 closed out, a net change of -16 holders.
  • The largest Voyager Therapeutics buyer in Q1 2020 was Armistice Capital, an estimated $7.02M added.
  • The largest Voyager Therapeutics seller in Q1 2020 was Federated Hermes, an estimated $6.29M sold.

Based on aggregated 13F filings for Q1 2020.